Dr. Behzad Mahdavi is a distinguished strategic growth leader in the biopharma and pharmaceutical industries, renowned for his expertise in developing patient-centric growth strategies across various domains, including cell therapy, gene therapy, synthetic biology, personalized medicine, and life sciences. Currently, Dr. Mahdavi serves as the CEO of InnoGI Technologies and Executive Chairman at OpenCel Technologies.

With a career spanning over two decades, Dr. Mahdavi has held senior leadership roles at Lonza, Catalent Biopharma Solutions, and Ginkgo Bioworks. His proven track record showcases his ability to drive strategies that generate significant value and foster sustainable growth in emerging biopharma fields, with a profound impact on patient outcomes.

In addition to his professional accomplishments, Dr. Mahdavi is a member of the Forbes Technology Council and an active participant on multiple Boards of Directors and Advisory Boards. He holds a PhD in Chemistry and an MBA, and is the esteemed author of Mastering Commercial Innovation, a comprehensive guide on translating innovative ideas into profitable growth strategies.

Highly sought after as an advisor for both technology start-ups and established enterprises, Dr. Mahdavi offers invaluable expertise in fundraising, strategic development, innovation management, sales expansion, and the commercialization of disruptive technologies.